Journal of Clinical Oncology, Vol 16, 3761-3767, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital

AW Walter, ML Hancock, CH Pui, MM Hudson, JS Ochs, GK Rivera, CB Pratt, JM Boyett and LE Kun
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. andrew.walter@stjude.org

PURPOSE: To evaluate the incidence of and potential risk factors for second malignant neoplasms of the brain following treatment for childhood acute lymphoblastic leukemia (ALL). PATIENTS AND METHODS: The study population consisted of 1,612 consecutively enrolled protocol patients treated on sequential institutional protocols for newly diagnosed ALL at St Jude Children's Research Hospital (SJCRH) between 1967 and 1988. The median follow-up duration is 15.9 years (range, 5.5 to 29.9 y). RESULTS: The cumulative incidence of brain tumors at 20 years is 1.39% (95% confidence interval [CI], 0.63% to 2.15%). Twenty- two brain tumors (10 high-grade gliomas, one low-grade glioma, and 11 meningiomas) were diagnosed among 21 patients after a median latency of 12.6 years (high-grade gliomas, 9.1 years; meningiomas, 19 years). Tumor type was linked to outcome, with patients who developed high- grade tumors doing poorly and those who developed low-grade tumors doing well. Risk factors for developing any secondary brain tumor included the presence of CNS leukemia at diagnosis, treatment on Total X therapy, and the use of cranial irradiation, which was dose- dependent. Age less than 6 years was associated with an increased risk of developing a high-grade glioma. CONCLUSION: This single-institution study, with a high rate of long-term data capture, demonstrated that brain tumors are a rare, late complication of therapy for ALL. We report many more low-grade tumors than others probably because of exhaustive long-term follow-up evaluation. The importance of limiting cranial radiation is underscored by the dose-dependent tumorigenic effect of radiation therapy seen in this study.

This article has been cited by other articles:

				A. Moricke, A. Reiter, M. Zimmermann, H. Gadner, M. Stanulla, M. Dordelmann, L. Loning, R. Beier, W.-D. Ludwig, R. Ratei, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Blood, May 1, 2008; 111(9): 4477 - 4489. [Abstract] [Full Text] [PDF]

				B. M. Costa, P. Ferreira, S. Costa, P. Canedo, P. Oliveira, A. Silva, F. Pardal, G. Suriano, J. C. Machado, J. M. Lopes, et al. Association between Functional EGF+61 Polymorphism and Glioma Risk Clin. Cancer Res., May 1, 2007; 13(9): 2621 - 2626. [Abstract] [Full Text] [PDF]

				N. Hijiya, M. M. Hudson, S. Lensing, M. Zacher, M. Onciu, F. G. Behm, B. I. Razzouk, R. C. Ribeiro, J. E. Rubnitz, J. T. Sandlund, et al. Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia JAMA, March 21, 2007; 297(11): 1207 - 1215. [Abstract] [Full Text] [PDF]

				A. T. Meadows Pediatric Cancer Survivorship: Research and Clinical Care J. Clin. Oncol., November 10, 2006; 24(32): 5160 - 5165. [Abstract] [Full Text] [PDF]

				J. P. Neglia, L. L. Robison, M. Stovall, Y. Liu, R. J. Packer, S. Hammond, Y. Yasui, C. E. Kasper, A. C. Mertens, S. S. Donaldson, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst, November 1, 2006; 98(21): 1528 - 1537. [Abstract] [Full Text] [PDF]

				M. Buyukpamukcu, A. Varan, N. Yazici, N. Akalan, F. Soylemezoglu, F. Zorlu, C. Akyuz, and M. T. Kutluk Second Malignant Neoplasms Following the Treatment of Brain Tumors in Children J Child Neurol, May 1, 2006; 21(5): 433 - 436. [Abstract] [PDF]

				B. Burkhardt, W. Woessmann, M. Zimmermann, U. Kontny, J. Vormoor, W. Doerffel, G. Mann, G. Henze, F. Niggli, W.-D. Ludwig, et al. Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System-Negative Stage III or IV Lymphoblastic Lymphoma J. Clin. Oncol., January 20, 2006; 24(3): 491 - 499. [Abstract] [Full Text] [PDF]

				W. Y. Au, K. N. Hung, T. S. Wan, and E. Ma Side Effects Related to Cancer Treatment: CASE 3. Primary Cerebral Lymphoma After Radiotherapy for Recurrent Meningioma J. Clin. Oncol., November 20, 2005; 23(33): 8535 - 8536. [Full Text] [PDF]

				K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF]

				E. Vazquez, A. Castellote, J. Piqueras, P. Ortuno, J. Sanchez-Toledo, P. Nogues, and J. Lucaya Second Malignancies in Pediatric Patients: Imaging Findings and Differential Diagnosis RadioGraphics, September 1, 2003; 23(5): 1155 - 1172. [Abstract] [Full Text] [PDF]

				C.-H. Pui, C. Cheng, W. Leung, S. N. Rai, G. K. Rivera, J. T. Sandlund, R. C. Ribeiro, M. V. Relling, L. E. Kun, W. E. Evans, et al. Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia N. Engl. J. Med., August 14, 2003; 349(7): 640 - 649. [Abstract] [Full Text] [PDF]

				M. Clarke, P. Gaynon, I. Hann, G. Harrison, G. Masera, R. Peto, and S. Richards CNS-Directed Therapy for Childhood Acute Lymphoblastic Leukemia: Childhood ALL Collaborative Group Overview of 43 Randomized Trials J. Clin. Oncol., May 1, 2003; 21(9): 1798 - 1809. [Abstract] [Full Text] [PDF]

				D. L. Preston, E. Ron, S. Yonehara, T. Kobuke, H. Fujii, M. Kishikawa, M. Tokunaga, S. Tokuoka, and K. Mabuchi Tumors of the Nervous System and Pituitary Gland Associated With Atomic Bomb Radiation Exposure J Natl Cancer Inst, October 16, 2002; 94(20): 1555 - 1563. [Abstract] [Full Text] [PDF]

				S. Bhatia, H. N. Sather, O. B. Pabustan, M. E. Trigg, P. S. Gaynon, and L. L. Robison Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983 Blood, May 29, 2002; 99(12): 4257 - 4264. [Abstract] [Full Text] [PDF]

				P. C. Kolb Smith The Role of the Primary Care Advanced Practice Nurse in Evaluating and Monitoring Childhood Cancer Survivors for a Second Malignant Neoplasm Journal of Pediatric Oncology Nursing, May 1, 2002; 19(3): 84 - 96. [Abstract] [PDF]

				D. Hoelzer, N. Gokbuget, O. Ottmann, C.-H. Pui, M. V. Relling, F. R. Appelbaum, J. J.M. van Dongen, and T. Szczepanski Acute Lymphoblastic Leukemia Hematology, January 1, 2002; 2002(1): 162 - 192. [Abstract] [Full Text] [PDF]

				E. Lubin, P. R. Sullivan, and L. M. DeAngelis Brain Tumors N. Engl. J. Med., May 10, 2001; 344(19): 1478 - 1479. [Full Text]

				L. M. DeAngelis Brain Tumors N. Engl. J. Med., January 11, 2001; 344(2): 114 - 123. [Full Text] [PDF]

				E. Obedian, D. B. Fischer, and B. G. Haffty Second Malignancies After Treatment of Early-Stage Breast Cancer: Lumpectomy and Radiation Therapy Versus Mastectomy J. Clin. Oncol., June 12, 2000; 18(12): 2406 - 2412. [Abstract] [Full Text] [PDF]

				L. Loning, M. Zimmermann, A. Reiter, P. Kaatsch, G. Henze, H. Riehm, and M. Schrappe Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy Blood, May 1, 2000; 95(9): 2770 - 2775. [Abstract] [Full Text] [PDF]

				G. Socie, R. E. Curtis, H. J. Deeg, K. A. Sobocinski, A. H. Filipovich, L. B. Travis, K. M. Sullivan, P. A. Rowlings, D. W. Kingma, P. M. Banks, et al. New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia J. Clin. Oncol., January 14, 2000; 18(2): 348 - 348. [Abstract] [Full Text] [PDF]